Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing
Archives of Microbiology · 2024-04 · 206 (4)
DOI: 10.1007/s00203-024-03921-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, online erschienen am 14.03.2024. Verfasst von Sethuraman Prem Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Quality Assurance, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203,…. Hauptthemen laut MEDLINE: Burkholderia cepacia complex, Burkholderia Infections, Cystic Fibrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Burkholderia cepacia complex (BCC) is a Gram-negative, non-spore-forming bacterium with more than 20 opportunistic pathogenic species, most commonly found in soil and water. Due to their rapid mutation rates, these organisms are adaptable and possess high genomic plasticity. BCC can cause life-threatening infections in immunocompromised individuals, such as those with cystic fibrosis, chronic granulomatous disease, and neonates. BCC contamination is a significant concern in pharmaceutical manufacturing, frequently causing non-sterile product recalls. BCC has been found in purified water, cosmetics, household items, and even ultrasound gel used in veterinary practices. Pharmaceuticals, personal care products, and cleaning solutions have been implicated in numerous outbreaks worldwide, highlighting the risks associated with intrinsic manufacturing site contamination. Regulatory compliance, product safety, and human health protection depend on testing for BCC in pharmaceutical manufacturing. Identification challenges exist, with BCC often misidentified as other bacteria like non-lactose fermenting Escherichia coli or Pseudomonas spp., particularly in developing countries where reporting BCC in pharmaceuticals remains limited. This review comprehensively aims to address the organisms causing BCC contamination, genetic diversity, identification challenges, regulatory requirements, and mitigation strategies. Recommendations are proposed to aid pharmaceutical chemists in managing BCC-associated risks and implementing prevention strategies within manufacturing processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Quality Assurance, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
- Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
- Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
- Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.
- Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India. pazhanigp@gmail.com.
ORCID-Profile: Gururaja Perumal Pazhani
Zitieren
APA
Kumar, S. P., Uthra, K. T., Chitra, V., Damodharan, N., & Pazhani, G. P. (2024). Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing. Archives of Microbiology, 206(4). https://doi.org/10.1007/s00203-024-03921-9
Vancouver
Kumar SP, Uthra KT, Chitra V, Damodharan N, Pazhani GP. Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing. Archives of Microbiology. 2024;206(4). doi:10.1007/s00203-024-03921-9
BibTeX
@article{Kumar2024,
author = {Kumar, Sethuraman Prem and Uthra, Karupanagounder Thangaraj and Chitra, Vellapandian and Damodharan, Narayanasamy and Pazhani, Gururaja Perumal},
title = {Challenges and mitigation strategies associated with Burkholderia cepacia complex contamination in pharmaceutical manufacturing},
journal = {Archives of Microbiology},
year = {2024},
volume = {206},
number = {4},
doi = {10.1007/s00203-024-03921-9}
}
EUVIMED